Patent · US Expired

Therapeutic peptides

US8143380B2 · kind B2 · utility

11Cited by
48References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 8, 2005
Grant dateMar 27, 2012
Priority date
Expiry dateDec 17, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds that exhibit improved bioefficacy in multidose administration. More specifically, the invention relates to polypeptides or peptides modified to include an antibody Fc region and one or more water soluble polymers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.